ZL300_00_001e_WL Guidance document Variations and extensions HMV4

First Page		Document Content
Health Pharmaceuticals policy Clinical research Federal Department of Home Affairs Swissmedic Pharmaceutical industry Healthcare quality Marketing authorization Statistical process control Pharmacovigilance IB Bioequivalence		ZL300_00_001e_WL Guidance document Variations and extensions HMV4 Add to Reading List Source URL: www.swissmedic.ch Download Document from Source Website File Size: 434,97 KB Share Document on Facebook

	Web-Scale Pharmacovigilance: Listening to Signals from the Crowd Ryen W. White Ph.D.1*, Nicholas P. Tatonetti Ph.D.2, Nigam H. Shah M.B.B.S. Ph.D.3, Russ B. Altman M.D. Ph.D.4 and Eric Horvitz M.D. Ph.D.1 1 Microsoft Re DocID: 1vpEW - View Document
	Centre Anti Poison et de Pharmacovigilance du Maroc Société Marocaine de Toxicologie DocID: 1v4Ie - View Document
	Microsoft Word - Simple guide to Veterinary Pharmacovigilance in the EU DocID: 1uY7F - View Document
	PREPARATION D’UN DIPLOME DE TOXICOLOGIE - PHARMACOVIGILANCE    DocID: 1uOXD - View Document
	Liste des inscrits à la formation de toxicologie pharmacovigilance Année 2005 – 2006 Module « Pharmacovigilance » Nom Abouali Fatima Achour Sanaa DocID: 1uKFW - View Document